日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis

Lenabasum 在系统性硬化症成人患者中的 II 期随机、安慰剂对照试验中的安全性和有效性

Spiera, Robert; Hummers, Laura; Chung, Lorinda; Frech, Tracy M; Domsic, Robyn; Hsu, Vivien; Furst, Daniel E; Gordon, Jessica; Mayes, Maureen; Simms, Robert; Lafyatis, Robert; Martyanov, Viktor; Wood, Tammara; Whitfield, Michael L; Constantine, Scott; Lee, Elizabeth; Dgetluck, Nancy; White, Barbara

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

一项随机、双盲、安慰剂对照研究,旨在评估α7尼古丁乙酰胆碱受体激动剂恩西尼克林治疗精神分裂症认知障碍的疗效。

Keefe, Richard S E; Meltzer, Herbert A; Dgetluck, Nancy; Gawryl, Maria; Koenig, Gerhard; Moebius, Hans J; Lombardo, Ilise; Hilt, Dana C

Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale

精神分裂症认知评定量表的信度、效度和治疗敏感性

Keefe, Richard S E; Davis, Vicki G; Spagnola, Nathan B; Hilt, Dana; Dgetluck, Nancy; Ruse, Stacy; Patterson, Thomas D; Narasimhan, Meera; Harvey, Philip D